122 related articles for article (PubMed ID: 12670736)
1. Caveolae, estrogen and nitric oxide.
Zhu W; Smart EJ
Trends Endocrinol Metab; 2003 Apr; 14(3):114-7. PubMed ID: 12670736
[TBL] [Abstract][Full Text] [Related]
2. Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae.
Chambliss KL; Shaul PW
Steroids; 2002 May; 67(6):413-9. PubMed ID: 11960616
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects.
Stirone C; Boroujerdi A; Duckles SP; Krause DN
Mol Pharmacol; 2005 Jan; 67(1):105-13. PubMed ID: 15496504
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae.
Chambliss KL; Yuhanna IS; Mineo C; Liu P; German Z; Sherman TS; Mendelsohn ME; Anderson RG; Shaul PW
Circ Res; 2000 Nov; 87(11):E44-52. PubMed ID: 11090554
[TBL] [Abstract][Full Text] [Related]
5. Estrogen modulation of endothelial nitric oxide synthase.
Chambliss KL; Shaul PW
Endocr Rev; 2002 Oct; 23(5):665-86. PubMed ID: 12372846
[TBL] [Abstract][Full Text] [Related]
6. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae.
Kim HP; Lee JY; Jeong JK; Bae SW; Lee HK; Jo I
Biochem Biophys Res Commun; 1999 Sep; 263(1):257-62. PubMed ID: 10486286
[TBL] [Abstract][Full Text] [Related]
7. Rapid, estrogen receptor-mediated signaling: why is the endothelium so special?
Kim KH; Bender JR
Sci STKE; 2005 Jun; 2005(288):pe28. PubMed ID: 15956360
[TBL] [Abstract][Full Text] [Related]
8. Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase.
Simoncini T; Genazzani AR
J Clin Endocrinol Metab; 2000 Aug; 85(8):2966-9. PubMed ID: 10946913
[TBL] [Abstract][Full Text] [Related]
9. Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae.
Mineo C; Shaul PW
Cardiovasc Res; 2006 Apr; 70(1):31-41. PubMed ID: 16540099
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells.
Schwartz EA; Reaven E; Topper JN; Tsao PS
Biochem J; 2005 Aug; 390(Pt 1):199-206. PubMed ID: 15819614
[TBL] [Abstract][Full Text] [Related]
11. Regulation of endothelial nitric oxide synthase and high-density lipoprotein quality by estradiol in cardiovascular pathology.
Kypreos KE; Zafirovic S; Petropoulou PI; Bjelogrlic P; Resanovic I; Traish A; Isenovic ER
J Cardiovasc Pharmacol Ther; 2014 May; 19(3):256-68. PubMed ID: 24414281
[TBL] [Abstract][Full Text] [Related]
12. ERbeta has nongenomic action in caveolae.
Chambliss KL; Yuhanna IS; Anderson RG; Mendelsohn ME; Shaul PW
Mol Endocrinol; 2002 May; 16(5):938-46. PubMed ID: 11981029
[TBL] [Abstract][Full Text] [Related]
13. Caveolae and caveolins in the cardiovascular system.
Gratton JP; Bernatchez P; Sessa WC
Circ Res; 2004 Jun; 94(11):1408-17. PubMed ID: 15192036
[TBL] [Abstract][Full Text] [Related]
14. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells.
Haynes MP; Sinha D; Russell KS; Collinge M; Fulton D; Morales-Ruiz M; Sessa WC; Bender JR
Circ Res; 2000 Oct; 87(8):677-82. PubMed ID: 11029403
[TBL] [Abstract][Full Text] [Related]
15. Cell surface estrogen receptors coupled to cNOS mediate immune and vascular tissue regulation: therapeutic implications.
Stefano GB; Peter D
Med Sci Monit; 2001; 7(5):1066-74. PubMed ID: 11535959
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
17. Augmented endothelial nitric oxide synthase (eNOS) protein expression in human pregnant myometrium: possible involvement of eNOS promoter activation by estrogen via both estrogen receptor (ER)alpha and ERbeta.
Kakui K; Itoh H; Sagawa N; Yura S; Korita D; Takemura M; Miyamaoto Y; Saito Y; Nakao K; Fujii S
Mol Hum Reprod; 2004 Feb; 10(2):115-22. PubMed ID: 14742696
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells.
Okano H; Jayachandran M; Yoshikawa A; Miller VM
J Cardiovasc Pharmacol; 2006 Apr; 47(4):621-8. PubMed ID: 16680078
[TBL] [Abstract][Full Text] [Related]
19. Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis.
Shaul PW
J Physiol; 2003 Feb; 547(Pt 1):21-33. PubMed ID: 12562964
[TBL] [Abstract][Full Text] [Related]
20. Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells.
Maniatis NA; Brovkovych V; Allen SE; John TA; Shajahan AN; Tiruppathi C; Vogel SM; Skidgel RA; Malik AB; Minshall RD
Circ Res; 2006 Oct; 99(8):870-7. PubMed ID: 16973909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
